# Pfizer - Market Position & Products

**Generated:** 2025-12-09 00:10

*Market cap, valuation, products and services*

---

## Market Position

### Market Capitalization and Stock Performance
- **Market Cap**: $148.00B
- **Current Stock Price**: Data not available
- **52-Week High**: $27.21
- **52-Week Low**: $19.83
- **Exchange**: NYSE (Ticker: PFE)

### Market Share and Competitive Positioning
Pfizer operates as a leading player in the drug manufacturers - general industry within the healthcare sector.

### Valuation Metrics
- **Dividend Yield**: 6.61%
- **Sector**: Healthcare
- **Industry**: Drug Manufacturers - General

## Products & Services

### Major Product Lines
- **COVID-19 Products**: Continued revenue contribution expected in 2025 guidance
- **Oncology Portfolio**: Significantly expanded through Seagen acquisition
- **Obesity Treatments**: Portfolio of mid- and early-stage obesity assets including GLP-1s and amylins
- **mRNA Therapeutics**: Partnership with BioNTech for serious diseases including cancer, COVID-19, and malaria

### Recent Product Developments (2024-2025)
- **Pipeline Update**: Product pipeline updated as of November 4, 2025, featuring investigational medicines and vaccines
- **Obesity Assets**: Development of three obesity-focused compounds including GLP-1s, amylins, and potential combinations

### Key Services
The company focuses primarily on pharmaceutical products rather than services.

---

*This is part of the Pfizer research report. See [Full Report](00_full_report.md) for complete analysis.*
